Efficacy and Safety of Simeprevir plus Sofosbuvir plus Ribavirin Flat Dose in a Population of Naive and Experienced HCV Genotype 1 Cirrhotic Elderly Patients: A Real World Experience from CLEO Group

Autor:	R. Villani, Paola Begini, C. D'Ambrosio, Massimo Marignani, A. Barlattani, G. Scifo, L. Fondacaro, L. Alessio, Giorgio Barbarini, O. Armignacco, Antonio Ascione, P. Guarascio, Giuseppe Maria Ettorre, Pascal Vignally, L. Fontanella, E.D amico, A. Moretti, Pierluigi Tarquini, Vincenzo Messina, Adriano M. Pellicelli, G. Cerasari, Valeria Pace Palitti, Antonio Izzi
Rok vydání:	2016
Předmět:	Simeprevir medicine.medical_specialty education.field_of_study Hepatology Sofosbuvir business.industry Ribavirin Population Virology chemistry.chemical_compound chemistry Hcv genotype 1 Internal medicine medicine education business medicine.drug
Zdroj:	Journal of Hepatology. 64:S245
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(16)00254-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f3975f3b87e02c383d694ecaeb36d98d https://doi.org/10.1016/s0168-8278(16)00254-3 Zobrazit plný text záznamu Full Text from ScienceDirect